20 studies found for:    "Exfoliative dermatitis"
Show Display Options
Rank Status Study
1 Terminated A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris
Condition: Pityriasis Rubra Pilaris
Intervention: Drug: Alefacept
2 Active, not recruiting A Phase 3 Clinical Study of KHK 4827
Conditions: Psoriasis Vulgaris,;   Psoriatic Arthritis,;   Pustular Psoriasis,;   Psoriatic Erythroderma
Interventions: Drug: KHK4827 140mg SC;   Drug: KHK4827 210mg SC
3 Completed A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis
Conditions: Plaque Psoriasis;   Psoriatic Arthritis;   Pustular Psoriasis (Excluding a Localized);   Psoriatic Erythroderma
Intervention: Drug: TA-650
4 Unknown  National Registry for Ichthyosis and Related Disorders
Conditions: Darier Disease;   Hailey-Hailey Disease;   Hyperkeratosis, Epidermolytic;   Ichthyosis;   Ichthyosis, Lamellar;   Ichthyosis, X-Linked;   Keratoderma
Intervention:
5 Completed An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis
Condition: Psoriasis
Intervention: Drug: KHK4827
6 Recruiting Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M
Conditions: Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV);   Neutral Lipid Storage Disease With Myopathy (NLSD-M)
Intervention: Dietary Supplement: CNT-02
7 Recruiting A Multi-center, Prospective Evaluation of Infants and Children With Congenital Ichthyosis
Condition: Ichthyosis
Intervention: Other: Observation
8 Recruiting Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy
Conditions: Metabolism, Inborn Errors;   Lipid Metabolism, Inborn Errors;   Carbohydrate Metabolism, Inborn Errors;   Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency;   Glycogenin-1 Deficiency (Glycogen Storage Disease Type XV);   Carnitine Palmitoyl Transferase 2 Deficiency;   VLCAD Deficiency;   Medium-chain Acyl-CoA Dehydrogenase Deficiency;   Multiple Acyl-CoA Dehydrogenase Deficiency;   Carnitine Transporter Deficiency;   Neutral Lipid Storage Disease;   Glycogen Storage Disease Type II;   Glycogen Storage Disease Type III;   Glycogen Storage Disease Type IV;   Glycogen Storage Disease Type V;   Muscle Phosphofructokinase Deficiency;   Phosphoglucomutase 1 Deficiency;   Phosphoglycerate Mutase Deficiency;   Phosphoglycerate Kinase Deficiency;   Phosphorylase Kinase Deficiency;   Beta Enolase Deficiency;   Lactate Dehydrogenase Deficiency;   Glycogen Synthase Deficiency
Intervention: Other: Sugar
9 Completed The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM)
Condition: Neutral Lipid Storage Disease
Intervention: Drug: Fibrate treatment
10 Unknown  Treatment of the Recessive Nonbullous Congenital Ichthyosis by the Epigallocatechine Cutaneous
Condition: Lamellar Ichthyosis
Intervention: Drug: apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side
11 Completed Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell Lymphoma
Conditions: Mycosis Fungicides;   Sezary Syndrome;   Dermatitis;   Dermatitis, Exfoliative
Intervention: Other: Detection of KIR receptor by RT PCR
12 Active, not recruiting Clinical Trial Using Humira in Netherton Syndrome
Condition: Netherton Syndrome
Intervention: Drug: Adalimumab
13 Recruiting Natural History and Biological Study of Netherton Syndrome
Conditions: Netherton Syndrome;   Healthy
Interventions: Other: Biopsy;   Other: Blood sample
14 Recruiting Gene Therapy for Netherton Syndrome
Condition: Netherton Syndrome
Intervention: Genetic: One 20cm2/10cm2 autologous skin sheet graft
15 Completed A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome
Conditions: Healthy Volunteers;   Atopic Dermatitis;   Netherton Syndrome
Interventions: Drug: BPR277 ointment (controlled application);   Drug: Placebo (Vehicle);   Drug: BPR277 ointment;   Drug: BPR277
16 Withdrawn Novel Treatment for Syndromic Ichthyoses
Conditions: Syndromic Ichthyoses;   CHILD Syndrome;   Smith Lemli Opitz Syndrome;   Conradi Syndrome
Intervention: Drug: Lovastatin
17 Completed
Has Results
Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population
Conditions: Atopic Dermatitis;   Ichthyosis Vulgaris
Intervention: Genetic: Buccal Swab
18 Completed Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar Ichthyosis
Condition: Ichthyosis, Lamellar
Intervention: Drug: Liarozole
19 Completed
Has Results
Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome
Condition: Netherton Syndrome
Intervention: Drug: Pimecrolimus 1% Cream
20 Completed Study of Scaling Disorders and Other Inherited Skin Diseases
Conditions: Genetic Skin Disease;   Keratosis Follicularis;   Lamellar Ichthyosis
Intervention:

Indicates status has not been verified in more than two years